Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

被引：0

作者：

Cabibbo, G. ^{[1
]}

Cacciola, I. ^{[2
]}

Cannavo, M. R. ^{[3
]}

Madonia, S. ^{[4
]}

Calvaruso, V. ^{[5
]}

Petta, S. ^{[1
]}

Di Stefano, M. ^{[6
]}

Larocca, L. ^{[7
]}

Prestileo, T. ^{[8
]}

Tine, F. ^{[9
]}

Digiacomo, A. ^{[10
]}

Bertino, G. ^{[11
]}

Giannitrapani, L. ^{[12
]}

Benanti, F. ^{[13
]}

Davi, A. ^{[14
]}

Volpes, R. ^{[15
]}

Guarneri, L. ^{[16
]}

Averna, A. ^{[17
]}

Scalisi, I. ^{[18
]}

Iacobello, C. ^{[19
]}

Mazzola, G. ^{[20
]}

Cartabellotta, F. ^{[21
]}

Portelli, V. ^{[22
]}

Russello, M. ^{[23
]}

Scifo, G. ^{[24
]}

Squadrito, G. ^{[25
]}

Raimondo, G. ^{[25
]}

Craxi, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

机构：

[1] Univ Palermo, Gastroenterol & Epatol, DIBIMIS, Palermo, Italy

[2] AOUP G Di Martino, Epatol Clin & Mol, Messina, Italy

[3] ARNAS Garibaldi Nesima, UOD Epatol, Catania, Italy

[4] AO Cervello Villa Sofia, Med Interna, Palermo, Italy

[5] Univ Palermo, Gastroenterol & Epatol, Palermo, Italy

[6] UmbertoIO, Malattie Infett, Siracusa, Italy

[7] AOUP Vittorio Emanuele, Malattie INfett, Catania, Italy

[8] ARNAS Civ Di Cristina Benefratelli, Malattie Infett, Palermo, Italy

[9] AO Cervello Villa Sofia, Gastroenterol, Palermo, Italy

[10] Presidio Osped, Med Interna, Comiso, Italy

[11] Vittorio Emanuele, Med Interna & Urgenza, Catania, Italy

[12] Univ Palermo, Med Interna, Palermo, Italy

[13] Garibaldi Nesima, Malattie Infett, Catania, Italy

[14] Presidio Osped Modica, Malattie Infett, Modica, Italy

[15] ISMETT, Palermo, Italy

[16] Umberto I, Malattie Infett, Enna, Italy

[17] S Elia, Malattie Infett, Caltanissetta, Italy

[18] Presidio Osped Castelvetrano, Med Interna, Trapani, Italy

[19] Cannizzaro, Malattie Infett, Catania, Italy

[20] Univ Palermo, Malattie Infett, Palermo, Italy

[21] Buccheri La Ferla, Med Interna, Palermo, Israel

[22] PO, Malattie Infett, Trapani, Israel

[23] Garibaldi, Gastroenterol, Catania, Italy

[24] Umberto I, Malattie Infett, Siracusa, Italy

[25] Univ Messina, Epatol Clin & Mol, Messina, Italy

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30734-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-096

引用

页码：S218 / S218

页数：1

共 50 条

[21] LOWER SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED FOR HEPATITIS C WITH DIRECT ACTING ANTIVIRALS
Nguyen, Kelvin T.
Konyn, Peter
Choi, Gina
Durazo, Francisco A.
Han, Steven-Huy
Ramirez, Samantha
Saab, Sammy
El-Kabany, Mohamed El-Kabany
GASTROENTEROLOGY, 2017, 152 (05) : S1097 - S1097
[22] A genetic risk score predicts de novo hepatocellular carcinoma in hepatits c cirrhotic patients treated with direct-acting antivirals
Degasperi, E.
Galmozzi, E.
Pelusi, S.
D'Ambrosio, R.
Soffredini, R.
Borghi, M.
Perbellini, R.
Facchetti, F.
Iavarone, M.
Sangiovanni, A.
Valenti, L.
Lampertico, P.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : E19 - E19
[23] Adherence to hepatocellular carcinoma screening in patients with hepatitis C cirrhosis treated with direct-acting antivirals against hepatitis C
Suarez Zambrano, Elisaul
Acosta-Lopez, Silvia
Diaz Bethencourt, Dacil
Soledad Garrido, Maria
Suarez Darias, Ruth
Perez Hernandez, Francisco Andres
JOURNAL OF HEPATOLOGY, 2022, 77 : S931 - S931
[24] No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
Mun, Elijah J.
Green, Pamela
Berry, Kristin
Ioannou, George N.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 47 - 52
[25] No Difference between Direct-Acting Antivirals for Hepatitis C in Hepatocellular Carcinoma Risk
Mun, Elijah
Green, Pamela
Berry, Kristin
Ioannou, George
HEPATOLOGY, 2018, 68 : 389A - 389A
[26] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
Harrod, Elizabeth
Agarwal, Ritu
Tabrizian, Parissa
Rayapudi, Madhavi
Ala, Aftab
Fiel, Isabel
Schwartz, Myron
Dieterich, Douglas
Friedman, Scott
Saberi, Behnam
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
[27] Recurrence of hepatocellular carcinoma in patients with complete response treated with direct acting antivirals in clinical practice
Perello, Christie
Llop, Elba
Fernandez Vazquez, Inmaculada
Matilla, Ana M.
Gea, Francisco
Garcia-Samaniego Rey, Francisco Javier
Martin, Ana
Garcia-Sanchez, Araceli
Banares, Rafael
Albillos, Agustin
Calleja Panero, Jose Luis
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E617 - E617
[28] Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Ramadan, Mohammad Said
Boccia, Filomena
Moretto, Simona Maria
De Gregorio, Fabrizio
Gagliardi, Massimo
Iossa, Domenico
Durante-Mangoni, Emanuele
Zampino, Rosa
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[29] OCCURRENCE AND RELAPSE OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C PATIENTS TREATED WITH ALL ORAL DIRECT-ACTING ANTIVIRALS
Fukuhara, Kyoko
Yamashina, Shunhei
Kon, Kazuyoshi
Uchiyama, Akira
Fukada, Hiroo
Shiina, Shuichiro
Ikejima, Kenichi
GASTROENTEROLOGY, 2019, 156 (06) : S1202 - S1202
[30] Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
Mercan-Stanciu, Adriana
Isac, Teodora
Rababoc, Razvan
Rusie, Daniel
Toma, Letitia
Vacaroiu, Ileana Adela
Tulin, Raluca
Iliescu, Elena Laura
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)

← 1 2 3 4 5 →